These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 9228715
1. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients. Taaning E, Simonsen AC, Hjelms E, Svejgaard A, Morling N. Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715 [Abstract] [Full Text] [Related]
2. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Brouk H, Bertrand G, Zitouni S, Djenouni A, Martageix C, Griffi F, Kaplan C, Ouelaa H. Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758 [Abstract] [Full Text] [Related]
5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D. Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051 [Abstract] [Full Text] [Related]
6. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A. Blood; 1995 Apr 01; 85(7):1736-41. PubMed ID: 7703481 [Abstract] [Full Text] [Related]
7. Alloimmunization as a problem for platelet transfusion. Bonacossa IA. Transfus Med Rev; 1990 Apr 01; 4(2):144-8. PubMed ID: 2134622 [No Abstract] [Full Text] [Related]
11. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization. Murphy MF, Metcalfe P, Thomas H, Eve J, Ord J, Lister TA, Waters AH. Br J Haematol; 1986 Mar 01; 62(3):529-34. PubMed ID: 3954967 [Abstract] [Full Text] [Related]
12. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Brand A, Claas FH, Voogt PJ, Wasser MN, Eernisse JG. Vox Sang; 1988 Mar 01; 54(3):160-6. PubMed ID: 3369136 [Abstract] [Full Text] [Related]
14. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Lo SC, Chang JS, Lin SW, Lin DT. Transfusion; 2005 May 01; 45(5):761-5. PubMed ID: 15847666 [Abstract] [Full Text] [Related]
15. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients. Godeau B, Fromont P, Seror T, Duedari N, Bierling P. Br J Haematol; 1992 Jul 01; 81(3):395-400. PubMed ID: 1390213 [Abstract] [Full Text] [Related]
16. Frequency and causes of refractoriness in multiply transfused patients. Legler TJ, Fischer I, Dittmann J, Simson G, Lynen R, Humpe A, Riggert J, Schleyer E, Kern W, Hiddemann W, Köhler M. Ann Hematol; 1997 Apr 01; 74(4):185-9. PubMed ID: 9174547 [Abstract] [Full Text] [Related]
18. Frequency and characterization of platelet-specific antibodies in patients who received multiple platelet transfusions. Lo SC, Lin DT, Lin SW, Chang JS. J Formos Med Assoc; 2000 Dec 01; 99(12):902-5. PubMed ID: 11155742 [Abstract] [Full Text] [Related]
19. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S. Transfus Med; 2018 Feb 01; 28(1):40-46. PubMed ID: 28516675 [Abstract] [Full Text] [Related]